Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells

被引:34
作者
Burwell, E. A. [1 ]
McCarty, G. P. [1 ]
Simpson, L. A. [1 ]
Thompson, K. A. [1 ]
Loeb, D. M. [1 ]
机构
[1] Johns Hopkins Univ, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
关键词
breast cancer; oncogene; epithelial-mesenchymal transition; cell cycle; alternative splicing;
D O I
10.1038/sj.onc.1210127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The role of WT1 (Wilm's tumor suppressor gene) in breast cancer is controversial, with evidence for both tumor-promoting and tumor-suppressing activities. In order to address this question, we expressed different WT1 isoforms in the mammary epithelial cell line H16N-2, which does not express endogenous WT1. Cells were stably transfected with either WT1 (- Ex5/ - KTS) or WT1 ( + Ex5/ + KTS) under the control of the inducible metallothionein promoter. Induction of WT1 (- Ex5/ - KTS) upregulated p21, causing a slowing of proliferation and a G2-phase cell cycle arrest. In artificial basement membrane, the WT1 (- Ex5/ - KTS) isoform promoted the appearance of highly organized acinar cellular aggregates. In contrast, WT1 (+ Ex5/ + KTS) had no effect on p21 or proliferation, but rather caused an epithelial-mesenchymal transition and a redistribution of E-cadherin from the cell membrane to the cytoplasm. This isoform also causes the cellular aggregates growing in artificial basement membrane to appear significantly less organized than control cells. Thus, different WT1 isoforms have distinct effects in this cell line, suggesting that depending on the ratio of WT1 isoform expression in mammary epithelial cells, WT1 could function to either promote or suppress a transformed phenotype.
引用
收藏
页码:3423 / 3430
页数:8
相关论文
共 24 条
[1]
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis [J].
Bärlund, M ;
Forozan, F ;
Kononen, J ;
Bubendorf, L ;
Chen, YD ;
Bittner, ML ;
Torhorst, J ;
Haas, P ;
Bucher, C ;
Sauter, G ;
Kallioniemi, OP ;
Kallioniemi, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) :1252-1259
[2]
WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes [J].
Davies, RC ;
Calvio, C ;
Bratt, E ;
Larsson, SH ;
Lamond, AI ;
Hastie, ND .
GENES & DEVELOPMENT, 1998, 12 (20) :3217-3225
[3]
Englert C, 1997, CANCER RES, V57, P1429
[4]
ALTERNATIVE SPLICING AND GENOMIC STRUCTURE OF THE WILMS-TUMOR GENE-WT1 [J].
HABER, DA ;
SOHN, RL ;
BUCKLER, AJ ;
PELLETIER, J ;
CALL, KM ;
HOUSMAN, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9618-9622
[5]
Hewitt SM, 1996, ANTICANCER RES, V16, P621
[6]
Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells [J].
Inoue, K ;
Tamaki, H ;
Ogawa, H ;
Oka, Y ;
Soma, T ;
Tatekawa, T ;
Oji, Y ;
Tsuboi, A ;
Kim, EH ;
Kawakami, M ;
Akiyama, T ;
Kishimoto, T ;
Sugiyama, H .
BLOOD, 1998, 91 (08) :2969-2976
[7]
REGULATION OF THE EXPRESSION OF THE VEGF/VPS AND ITS RECEPTORS - ROLE IN TUMOR ANGIOGENESIS [J].
KOLCH, W ;
MARTINYBARON, G ;
KIESER, A ;
MARME, D .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (02) :139-155
[8]
SUBNUCLEAR LOCALIZATION OF WT1 IN SPLICING OR TRANSCRIPTION FACTOR DOMAINS IS REGULATED BY ALTERNATIVE SPLICING [J].
LARSSON, SH ;
CHARLIEU, JP ;
MIYAGAWA, K ;
ENGELKAMP, D ;
RASSOULZADEGAN, M ;
ROSS, A ;
CUZIN, F ;
VANHEYNINGEN, V ;
HASTIE, ND .
CELL, 1995, 81 (03) :391-401
[9]
EXPRESSION OF THE ERBB3 GENE-PRODUCT IN BREAST-CANCER [J].
LEMOINE, NR ;
BARNES, DM ;
HOLLYWOOD, DP ;
HUGHES, CM ;
SMITH, P ;
DUBLIN, E ;
PRIGENT, SA ;
GULLICK, WJ ;
HURST, HC .
BRITISH JOURNAL OF CANCER, 1992, 66 (06) :1116-1121
[10]
LO HW, 2005, BREAST CANC RES TREA, V95, P1